- Report
- September 2019
- 399 Pages
Global
From €1306EUR$1,375USD£1,120GBP
€2613EUR$2,750USD£2,240GBP
- Report
- February 2018
- 192 Pages
Global
From €594EUR$625USD£509GBP
€1188EUR$1,250USD£1,018GBP
- Report
- April 2024
- 84 Pages
From €2423EUR$2,550USD£2,077GBP
€2850EUR$3,000USD£2,444GBP
- Report
- November 2022
- 125 Pages
Global
From €2366EUR$2,490USD£2,028GBP
- Report
- May 2023
- 180 Pages
Global
From €5653EUR$5,950USD£4,847GBP
- Report
- December 2022
- 150 Pages
Global
From €5653EUR$5,950USD£4,847GBP
- Report
- April 2023
- 150 Pages
Global
From €4608EUR$4,850USD£3,951GBP
- Report
- September 2022
- 62 Pages
Global
From €4703EUR$4,950USD£4,032GBP
- Report
- August 2022
- 60 Pages
Global
From €4703EUR$4,950USD£4,032GBP
- Report
- March 2022
- 61 Pages
Global
- Report
- April 2023
- 500 Pages
Global
From €3088EUR$3,250USD£2,648GBP
- Report
- May 2024
- 182 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- May 2024
- 182 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- April 2024
- 185 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- March 2023
- 119 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Report
- January 2022
- 200 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- October 2022
- 200 Pages
Global
From €2803EUR$2,950USD£2,403GBP
- Report
- May 2023
- 220 Pages
Global
From €3325EUR$3,500USD£2,851GBP
- Report
- January 2022
- 200 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,218GBP
The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more